๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Hexadecylphosphocholine does not influence phospholipase D and sphingomyelinase activity in human leukemia cells

โœ Scribed by Dinko Berkovic; Katharina Berkovic; Claudia Binder; Detlef Haase; Eduard A.M. Fleer


Book ID
114424685
Publisher
Wiley (Blackwell Publishing)
Year
2002
Tongue
English
Weight
162 KB
Volume
2
Category
Article
ISSN
1533-869X

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Changes in phospholipase D isoform activ
โœ Giusy Fiucci; Malgorzata Czarny; Yaakov Lavie; Di Zhao; Brygida Berse; J. Krzysz ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 171 KB

Multidrug resistance (MDR) is a major cause of failure of cancer chemotherapy and is often associated with elevated expression of drug transporters such as P-glycoprotein (P-gp) in the cancer cells. MDR is, however, accompanied by additional biochemical changes including modifications of membrane co

Lysophosphatidic acid stimulates phospho
โœ Chen Qi; Jin-Hyouk Park; Terra C. Gibbs; David W. Shirley; Cynthia D. Bradshaw; ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 325 KB

Phospholipase D (PLD) is activated in mammalian cells in response to a variety of growth factors and may play a role in cell proliferation. Lysophosphatidic acid (LPA) is a bioactive metabolite potentially generated as a result of PLD activation. Two human prostate cancer cell lines, PC-3 and LNCaP,